16-56885283-C-T

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong

The NM_001126108.2(SLC12A3):​c.1844C>T​(p.Ser615Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000309 in 1,553,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S615W) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000031 ( 0 hom. )

Consequence

SLC12A3
NM_001126108.2 missense

Scores

16
2
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 7.81
Variant links:
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.964
PP5
Variant 16-56885283-C-T is Pathogenic according to our data. Variant chr16-56885283-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 562346.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLC12A3NM_001126108.2 linkuse as main transcriptc.1844C>T p.Ser615Leu missense_variant 15/26 ENST00000563236.6 NP_001119580.2 P55017-1
SLC12A3NM_000339.3 linkuse as main transcriptc.1844C>T p.Ser615Leu missense_variant 15/26 NP_000330.3 P55017-2
SLC12A3NM_001126107.2 linkuse as main transcriptc.1841C>T p.Ser614Leu missense_variant 15/26 NP_001119579.2 P55017-3
SLC12A3NM_001410896.1 linkuse as main transcriptc.1841C>T p.Ser614Leu missense_variant 15/26 NP_001397825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLC12A3ENST00000563236.6 linkuse as main transcriptc.1844C>T p.Ser615Leu missense_variant 15/261 NM_001126108.2 ENSP00000456149.2 P55017-1
SLC12A3ENST00000438926.6 linkuse as main transcriptc.1844C>T p.Ser615Leu missense_variant 15/261 ENSP00000402152.2 P55017-2
SLC12A3ENST00000566786.5 linkuse as main transcriptc.1841C>T p.Ser614Leu missense_variant 15/261 ENSP00000457552.1 P55017-3
SLC12A3ENST00000262502.5 linkuse as main transcriptc.1841C>T p.Ser614Leu missense_variant 15/265 ENSP00000262502.5 J3QSS1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152190
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000375
AC:
6
AN:
159886
Hom.:
0
AF XY:
0.0000475
AC XY:
4
AN XY:
84160
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000860
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000798
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000314
AC:
44
AN:
1400880
Hom.:
0
Cov.:
30
AF XY:
0.0000333
AC XY:
23
AN XY:
691200
show subpopulations
Gnomad4 AFR exome
AF:
0.0000315
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000556
Gnomad4 SAS exome
AF:
0.0000126
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000315
Gnomad4 OTH exome
AF:
0.0000861
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152190
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74340
show subpopulations
Gnomad4 AFR
AF:
0.0000724
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000502
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.0000185
AC:
2

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial hypokalemia-hypomagnesemia Pathogenic:5
Pathogenic, criteria provided, single submitterclinical testingDivision Of Personalized Genomic Medicine, Columbia University Irving Medical CenterApr 13, 2020The c.1844C>T variant in the SLC12A3 gene is a heterozygous missense variant, which results in the substitution of the highly conserved serine residue at the 615 position to leucine (p.Ser615Leu). This variant localizes to coding exon 15 of the SLC12A3 gene (26 exons total; NM_000339.3). This variant is predicted to be deleterious and damaging to protein structure and/or function based on in silico analyses (PROVEAN and SIFT). This variant has been observed in the Genome Aggregation Database (gnomAD) at a very low frequency (allele frequency = 0.00004182, no homozygotes), indicating it is not a common benign variant in the populations represented in this database. This variant has been reported in multiple individuals with Gitelman syndrome either in the homozygous state or with another SLC12A3 variant (PMIDs: 11168953, 20552229, 30596175, 22728489, 22990302, 28251383, 17699451, 12112667, 27303630, 26770037). A different amino acid change at the same residue (p.S615W) has also been reported in an affected individual (PMID: 12112667). -
Pathogenic, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Likely pathogenic, criteria provided, single submitterclinical testingPathology and Clinical Laboratory Medicine, King Fahad Medical City-- -
Pathogenic, no assertion criteria providedclinical testingNatera, Inc.Aug 21, 2020- -
Pathogenic, criteria provided, single submitterclinical testingCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterDec 18, 2024- -
not provided Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingGeneDxAug 11, 2023In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30586318, 28700713, 20552229, 28251383, 11168953, 30596175, 22728489, 27303630, 22334612, 31398183, 28469853, 33348466, ATMI2018[Article], Parreira2015[article], 26121437, 32397528, 12112667, 25422309, 26770037, 22990302, 34426522, 31589614) -
Likely pathogenic, no assertion criteria providedresearchGharavi Laboratory, Columbia UniversitySep 16, 2018- -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 16, 2024This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 615 of the SLC12A3 protein (p.Ser615Leu). This variant is present in population databases (rs779160677, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of Gitelman syndrome (PMID: 11168953, 20552229, 22728489, 27303630, 30596175). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 562346). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC12A3 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.86
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
34
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.95
.;.;D;D
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Pathogenic
1.0
D;D;D;D
M_CAP
Pathogenic
0.32
D
MetaRNN
Pathogenic
0.96
D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.7
.;M;M;.
PrimateAI
Uncertain
0.66
T
PROVEAN
Pathogenic
-5.7
D;D;D;D
REVEL
Pathogenic
0.97
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Pathogenic
0.0010
D;D;D;D
Polyphen
0.94
P;D;D;.
Vest4
0.98
MVP
0.99
MPC
0.44
ClinPred
0.89
D
GERP RS
5.4
Varity_R
0.84
gMVP
0.94

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.16
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs779160677; hg19: chr16-56919195; API